DLBCL - Diffuse large B-cell lymphoma Back

External References: Wikipedia National Cancer Institute Google Scholar

iCoMut Beta for


Highly significantly mutated genes
CREBBP
14 patients (24%)
TP53
13 patients (22%)
MLL2
12 patients (20%)
CARD11
11 patients (18%)
TNFRSF14
8 patients (13%)
MYD88
7 patients (12%)
CD79B
7 patients (12%)
EZH2
6 patients (10%)
TNF
5 patients (8%)
CD70
5 patients (8%)
Significantly mutated genes
GNA13
9 patients (15%)
ITPKB
6 patients (10%)
POU2F2
4 patients (6%)
HLA-A
4 patients (6%)
BRAF
3 patients (5%)
POU2AF1
3 patients (5%)
Genes near significance
B2M
6 patients (10%)
BCL6
5 patients (8%)
HIST1H3B
4 patients (6%)
MAP2K1
4 patients (6%)
KRAS
3 patients (5%)
LTB
3 patients (5%)
STAT6
3 patients (5%)
NOTCH1
3 patients (5%)
PTEN
3 patients (5%)
ZNF471
2 patients (3%)
Click on a gene to see details.

Notes


• Gene name color indicates: known cancer genes | highly compelling novel candidate cancer genes | other candidates

Data details


Mutation list for DLBCL
Q-Q plots for DLBCL